Investment surges, hurdles and emerging innovations in neuroscience
Innovation in neuropsychiatry has been dormant for nearly forty years, said Kabir Nath, CEO, Compass Pathways in a panel discussion …
Innovation in neuropsychiatry has been dormant for nearly forty years, said Kabir Nath, CEO, Compass Pathways in a panel discussion …
The seemingly inexorable rise in global obesity is being reflected in the sales of diabetes and weight-loss drugs. One example …
Eisai has lowered the sales forecast for its Alzheimer’s drug Leqembi (lecanemab), primarily citing delays in revenue in the US. The …
Canadian biotech Aurinia Pharmaceuticals has announced it will be axing its workforce by 45% in a major restructuring plan aimed …
LakeShore Biopharma has commenced the submission of its biologics license application (BLA) to the Drug Regulatory Authority of Pakistan (DRAP) …
LakeShore Biopharma has commenced the submission of its biologics license application (BLA) to the Drug Regulatory Authority of Pakistan (DRAP) …
AstraZeneca and Amgen have released topline data from a Phase III trial of its inflammatory therapy, Tezspire (tezepelumab) in patients …
A target product profile (TPP) is a set of necessary attributes that the final drug product must have for the …
Mustang Bio has received orphan drug designation from the US Food and Drug Administration (FDA) for MB-108, a herpes simplex …
Sonnet BioTherapeutics has announced the issuance of US Patent No. 12,134,635 covering its two new drug candidates, SON-1411 and SON-1400, …
Santen Pharmaceutical and Arctic Vision have signed a commercial collaboration agreement for the ARVN001 suprachoroidal injectable suspension, a treatment for …
In the Canadian pharmaceutical industry, there were two private equity deals announced in Q3 2024, worth a total value of …
Analysis of the key themes driving private equity deal activity reveals that artificial intelligence accounted for three pharmaceutical deals announced …
Analysis of the key themes driving M&A activity reveals that ecommerce accounted for eight pharmaceutical deals announced in Q3 2024, …
Analysis of the key themes driving private equity deal activity reveals that COVID-19 accounted for two pharmaceutical deals announced in …